We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Viral Shah

Viral N. Shah MD

Assistant Professor of Medicine & Pediatrics, Barbara Davis Center for Diabetes, Adult Clinic, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Dr. Shah is a Board-Certified Adult Endocrinologist and an Associate Professor at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes.

Dr. Shah has served as principal investigator on several clinical trials of diabetes technologies and therapeutics. In a NIDDK funded R01, he is investigating effect of type 1 diabetes on bone fragility in older adults with long-standing type 1 diabetes.

Dr. Shah has served on many leadership positions such as steering committee member for T1D Exchange Clinic Registry (2016-2017), Communication director for diabetes technology interest group at the American Diabetes Association (2019-2020), Ad hoc member of 79th AD annual meeting planning subcommittee for Diabetes Technology, and American College of Endocrinology Self-Assessment Program writing committee member (202-2021). He is well published with over 100 research publications including original article, invited reviews, editorials, and book chapters. He is reviewer for many peer-reviewed indexed journals and grant reviewer for JDRF, ADA and NIH.

Disclosures

Dr. Shah reports grants and personal fees from Sanofi US, grants and personal fees from Dexcom Inc, grants from EyeNuk, grants and other from Jaeb Center for Health Research (Type 1 diabetes Exchange), grants from Center for Women' Health Research at University of Colorado, grants from DiaComp, NIH, grants from CCTSI University of Colorado,  outside the submitted work.

Recent Contributions to PracticeUpdate:

  1. Sotagliflozin Plus Insulin in Poorly Controlled T1D
  2. Diabetic Ketoacidosis Risk Factors and Prevention Strategies in Type 1 Diabetes
  3. The Omnipod Hybrid Closed-Loop System Improves Management in Adults, Adolescents, and Children With T1D
  4. Impact of Glycemic Control on Fracture Risk in People With Newly Diagnosed Type 1 Diabetes

Most Read This Week

Recently Updated